{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T02:22:35Z","timestamp":1775182955382,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jiac-j.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jiac.2024.07.015","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T01:20:42Z","timestamp":1721265642000},"page":"102475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effects of meropenem supply restriction: A multicenter retrospective study"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1463-8008","authenticated-orcid":false,"given":"Yoshimichi","family":"Koutake","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoji","family":"Nagasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Soejima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Tsukada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Hamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2024.07.015_bib1","doi-asserted-by":"crossref","first-page":"564","DOI":"10.2174\/092986709787458498","article-title":"Current status of newer carbapenems","volume":"16","author":"Bassetti","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jiac.2024.07.015_bib2","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1128\/AAC.00296-11","article-title":"Carbapenems: past, present, and future","volume":"55","author":"Papp-Wallace","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2024.07.015_bib3","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1093\/jac\/dkx181","article-title":"Sparing carbapenem usage","volume":"72","author":"Wilson","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2024.07.015_bib4","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-spectrum beta-lactamases: a clinical update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jiac.2024.07.015_bib5","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1128\/AAC.00338-07","article-title":"Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection","volume":"51","author":"Lodise","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2024.07.015_bib6","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1128\/AAC.01121-13","article-title":"Regional resistance surveillance program results for 12 Asia-Pacific nations (2011)","volume":"57","author":"Mendes","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2024.07.015_bib7","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.cmi.2019.03.030","article-title":"Current options for the treatment of infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in different groups of patients","volume":"25","author":"Guti\u00e9rrez-Guti\u00e9rrez","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 7","key":"10.1016\/j.jiac.2024.07.015_bib8","doi-asserted-by":"crossref","first-page":"S521","DOI":"10.1093\/cid\/ciz824","article-title":"Epidemiology and diagnostics of carbapenem resistance in Gram-negative bacteria","volume":"69","author":"Nordmann","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.jiac.2024.07.015_bib9","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jhin.2015.08.007","article-title":"Prevention and control of multidrug-resistant gram-negative bacteria: recommendations from a joint working party","volume":"92","author":"Wilson","year":"2016","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jiac.2024.07.015_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx176","article-title":"Prevalence of carbapenem-resistant Gram-negative infections in the United States predominated by Acinetobacter baumannii and Pseudomonas aeruginosa","volume":"4","author":"Cai","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jiac.2024.07.015_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.diagmicrobio.2012.11.009","article-title":"Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes","volume":"75","author":"van Duin","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2024.07.015_bib12","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3201\/eid2007.121004","article-title":"Deaths attributable to carbapenem-resistant Enterobacteriaceae infection","volume":"20","author":"Falagas","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiac.2024.07.015_bib13","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1046\/j.1469-0691.2000.00107.x","article-title":"Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs)","volume":"6","author":"Paterson","year":"2000","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2024.07.015_bib14","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.2147\/IDR.S373998","article-title":"Predictive value of a quick Pitt Bacteremia Score for prognosis of patients with bloodstream infection secondary to urinary tract infection: a retrospective cohort study","volume":"15","author":"Li","year":"2022","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jiac.2024.07.015_bib15","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/377200","article-title":"Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome","volume":"37","author":"Kang","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2024.07.015_bib16","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1128\/AAC.49.4.1306-1311.2005","article-title":"Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment","volume":"49","author":"Micek","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2024.07.015_bib17","first-page":"161","article-title":"Multicenter study of the risk factors and outcomes of bloodstream infections caused by carbapenem-non-susceptible Acinetobacter baumannii in Indonesia","volume":"7","author":"Anggraini","year":"2022","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.jiac.2024.07.015_bib18","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bjid.2016.08.001","article-title":"Impact of piperacillin-tazobactam shortage on meropenem use: implications for antimicrobial stewardship programs","volume":"20","author":"Barber","year":"2016","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.jiac.2024.07.015_bib19","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1128\/AAC.05560-11","article-title":"Changes in the use of broad-spectrum antibiotics after cefepime shortage: a time series analysis","volume":"56","author":"Pl\u00fcss-Suard","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2024.07.015_bib20","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/BF02000400","article-title":"Association of secondary and polymicrobial nosocomial bloodstream infections with higher mortality","volume":"12","author":"Pittet","year":"1993","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2024.07.015_bib21","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s100960000392","article-title":"Clinical significance of polymicrobial versus monomicrobial bacteremia involving Pseudomonas aeruginosa","volume":"19","author":"Aliaga","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2024.07.015_bib22","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/myc.12644","article-title":"The Pitt Bacteremia Score, Charlson Comorbidity Index and chronic disease score are useful tools for the prediction of mortality in patients with Candida bloodstream infection","volume":"60","author":"Vaquero-Herrero","year":"2017","journal-title":"Mycoses"},{"key":"10.1016\/j.jiac.2024.07.015_bib23","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s10096-008-0568-5","article-title":"Inappropriate initial antimicrobial therapy as a risk factor for mortality in patients with community-onset Pseudomonas aeruginosa bacteremia","volume":"27","author":"Cheong","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2024.07.015_bib24","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3346\/jkms.2010.25.7.992","article-title":"Bloodstream infections and clinical significance of healthcare-associated bacteremia: a multicenter surveillance study in Korean hospitals","volume":"25","author":"Son","year":"2010","journal-title":"J Kor Med Sci"},{"key":"10.1016\/j.jiac.2024.07.015_bib25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13054-017-1696-z","article-title":"Timing of appropriate empirical antimicrobial administration and outcome of adults with community-onset bacteremia","volume":"21","author":"Lee","year":"2017","journal-title":"Crit Care"},{"key":"10.1016\/j.jiac.2024.07.015_bib26","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/archinte.162.9.1021","article-title":"Characteristics of bacteremia between community-acquired and nosocomial Klebsiella pneumoniae infection: risk factor for mortality and the impact of capsular serotypes as a herald for community-acquired infection","volume":"162","author":"Tsay","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jiac.2024.07.015_bib27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1086\/514550","article-title":"Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials","volume":"25","author":"Elting","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2024.07.015_bib28","first-page":"137","article-title":"Chryseobacterium meningosepticum infection: antibiotic susceptibility and risk factors for mortality","volume":"41","author":"Hung","year":"2008","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jiac.2024.07.015_bib29","doi-asserted-by":"crossref","first-page":"e02483","DOI":"10.1128\/AAC.02483-18","article-title":"Clinical data on daptomycin plus ceftaroline versus standard of care monotherapy in the treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"63","author":"Geriak","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2024.07.015_bib30","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1093\/cid\/ciac364","article-title":"Persistent methicillin-resistant Staphylococcus aureus bacteremia: resetting the clock for optimal management","volume":"75","author":"Holland","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2024.07.015_bib31","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1128\/AAC.49.2.760-766.2005","article-title":"Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome","volume":"49","author":"Kang","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2024.07.015_bib32","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1128\/AAC.00143-10","article-title":"Cost of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy","volume":"54","author":"Tumbarello","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2024.07.015_bib33","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/cid\/ciz528","article-title":"The Pitt Bacteremia Score predicts mortality in non bacteremic infections","volume":"70","author":"Henderson","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2024.07.015_bib34","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2024.07.015_bib35","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10156-012-0423-6","article-title":"Methicillin-resistant Staphylococcus aureus bacteremia at a university hospital in Japan","volume":"18","author":"Isobe","year":"2012","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2024.07.015_bib36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jiac.2019.11.003","article-title":"Multicenter surveillance of the epidemiology of gram-negative bacteremia in Japan","volume":"26","author":"Kosai","year":"2020","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2024.07.015_bib37","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.2169\/internalmedicine.49.3360","article-title":"Relation between the antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa from respiratory specimens and antimicrobial use density (AUD) from 2005 through 2008","volume":"49","author":"Fukushima","year":"2010","journal-title":"Intern Med"},{"key":"10.1016\/j.jiac.2024.07.015_bib38","doi-asserted-by":"crossref","first-page":"339","DOI":"10.7150\/ijms.8.339","article-title":"The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey","volume":"8","author":"Altunsoy","year":"2011","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.jiac.2024.07.015_bib39","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1473-3099(21)00399-6","article-title":"Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicenter, cohort study","volume":"22","author":"Wang","year":"2022","journal-title":"Lancet Infect Dis"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24001934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24001934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T11:42:53Z","timestamp":1736768573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X24001934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1341321X24001934"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2024.07.015","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of meropenem supply restriction: A multicenter retrospective study","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2024.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102475"}}